Faster malaria testing

Bagchi, Sanjit
October 2007
CMAJ: Canadian Medical Association Journal;10/23/2007, Vol. 177 Issue 9, p1016
Academic Journal
The article reports on the market approval of Binax NOW, a rapid laboratory malaria test from Binax Inc., by the U.S. Food and Drug Administration (FDA). It was stated that FDA recognizes the new malaria test as significantly faster and easier to use than other existing method of diagnosing malaria. Binax NOW, which costs $10 to $29, could distinguish plasmodium falciparum infections from other less virulent malarial infections. Moreover, the test can provide results in 15 minutes from just a few drops of whole blood on a dipstick.


Related Articles

  • Rapid Diagnostic Testing for Malaria -- It's Finally Here! Deresinski, Stan // Infectious Disease Alert;Sep2007, Vol. 26 Issue 12, p133 

    The BinaxNOW® Malaria test, a 15 minute immunochromatographic test with a high sensitivity for the diagnosis of malaria due to Plasmodium falciparaum has been approved for use in the FDA.

  • Dateline Washington. Coorsh, Richard // Consumers' Research Magazine;Oct99, Vol. 82 Issue 10, p6 

    Announces the approval of the United States Food and Drug Administration on a test that determines whether a patient's pneumonia is caused by a certain type of bacteria. How the test developed by Binax Inc. works; Reason the test is important; Effect of the unnecessary use of antibiotics.

  • FDA Clears Rapid Blood Test for Malaria.  // Clinical Infectious Diseases;9/1/2007, Vol. 45 Issue 5, piv 

    The article reports on the approval of a new blood test that can identify malaria infections within 15 minutes by the Food and Drug Administration (FDA) in the U.S. According the FDA, the new Binax Now test was faster and easier to use compared to older methods. It gives results from a few drops...

  • Diagnostic Performance of Rapid Diagnostic Tests versus Blood Smears for Malaria in US Clinical Practice. Stauffer, William M.; Cartwright, Charles P.; Olson, Douglas A.; Juni, Billie Anne; Taylor, Charlotte M.; Bowers, Susan H.; Hanson, Kevan L.; Rosenblatt, Jon E.; Boulware, David R. // Clinical Infectious Diseases;9/15/2009, Vol. 49 Issue 6, p908 

    Background. Approximately 4 million US travelers to developing countries are ill enough to seek health care, with 1500 malaria cases reported in the United States annually. The diagnosis of malaria is frequently delayed because of the time required to prepare malaria blood films and lack of...

  • Malaria, be gone.  // Marketing Health Services;Fall2007, Vol. 27 Issue 3, p8 

    The article reveals that the U.S. Food and Drug Administration announced in June 2007 that it had cleared for marketing the Binax NOW Malaria Test, the first authorized U.S. rapid test for malaria. The author reports that the test, which is intended for laboratory use, is said to be better than...

  • IMI wins 510(k) clearance for BinaxNOW rapid malaria test. Young, Karen // Diagnostics & Imaging Week;7/5/2007, Vol. 10 Issue 27, p1 

    The article reports on the U.S. Food and Drug Administration(FDA) approval gained by Binax, a Scarborough, Maine-based subsidiary of diagnostics manufacturer Inverness Medical Solutions (IMI), for its BinaxNow rapid malaria test. Binax conducted clinical trails for the drug with the Walter Reed...

  • Coartem for Malaria in the United States. Deresinski, Stan // Infectious Disease Alert;Aug2009, Vol. 28 Issue 11, p93 

    The article reports on the approval issued by the U.S. Food and Drug Administration (FDA) for the use of Coartem® in the clinical treatment of acute, uncomplicated malaria in adults and children who weigh at least five kilograms. Coartem® is composed of 20 milligram (mg) artemether and 120...

  • Hot spot or not: a comparison of spatial statistical methods to predict prospective malaria infections. Mosha, Jacklin F.; Sturrock, Hugh J. W.; Greenwood, Brian; Sutherland, Colin J.; Gadalla, Nahla B; Atwal, Sharan; Hemelaar, Simon; Brown, Joelle M.; Drakeley, Chris; Kibiki, Gibson; Bousema, Teun; Chandramohan, Daniel; Gosling, Roland D. // Malaria Journal;2014, Vol. 13 Issue 1, p1 

    Background Within affected communities, Plasmodium falciparum infections may be skewed in distribution such that single or small clusters of households consistently harbour a disproportionate number of infected individuals throughout the year. Identifying these hotspots of malaria transmission...

  • Comparative performance of the ParaSight F test for detection of Plasmodium falciparum in malaria... Fryauff, D.J.; Gomez-Saladin, E.; Purnomo; Sumawinata, I.; Sutamihardja, M.A.; Tuti, S.; Subianto, B.; Richie, T.L. // Bulletin of the World Health Organization;1997, Vol. 75 Issue 6, p547 

    Compares the performance of the ParaSight F test for the detection of Plasmodium falciparum in blood from malaria-immune and nonimmune populations in Irian Jaya, Indonesia. Information pertaining to test; Where differences were seen; Method and results of the study conducted.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics